Found: 8
Select item for more details and to access through your institution.
Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 3, p. 364, doi. 10.1111/bjh.16090
- By:
- Publication type:
- Article
Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 3, p. 698, doi. 10.1002/cam4.1361
- By:
- Publication type:
- Article
Protein phosphatase methylesterase-1 (PME-1) expression predicts a favorable clinical outcome in colorectal cancer.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 12, p. 1798, doi. 10.1002/cam4.541
- By:
- Publication type:
- Article
The expression and distribution of group IIA phospholipase A2 in human colorectal tumours.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Combined epithelial marker analysis of tumour budding in stage II colorectal cancer.
- Published in:
- Journal of Pathology: Clinical Research, 2019, v. 5, n. 1, p. 63, doi. 10.1002/cjp2.119
- By:
- Publication type:
- Article
Incidence of solid cancer in patients with follicular lymphoma.
- Published in:
- Acta Oncologica, 2019, v. 58, n. 11, p. 1564, doi. 10.1080/0284186X.2019.1643918
- By:
- Publication type:
- Article
Securin identifies a subgroup of patients with poor outcome in rectal cancer treated with long-course (chemo)radiotherapy.
- Published in:
- Acta Oncologica, 2011, v. 50, n. 8, p. 1158, doi. 10.3109/0284186X.2011.584327
- By:
- Publication type:
- Article
Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer.
- Published in:
- PLoS ONE, 2017, v. 12, n. 9, p. 1, doi. 10.1371/journal.pone.0185436
- By:
- Publication type:
- Article